The Greek experience with efalizumab in psoriasis from a University Dermatologic Hospital

Abstract

These results confirm previous reports suggesting that treatment with efalizumab is an efficacious and safe option for patients with moderate-to-severe plaque psoriasis. A detailed previous history of psoriasis is important in order to select possible candidates for efalizumab therapy.